BLGO - BioLargo, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

BioLargo, Inc.

14921 Chestnut Street
Westminster, CA 92683
United States
949-643-9540
http://www.biolargo.com

SectorBasic Materials
IndustryChemicals
Full Time Employees29

Key Executives

NameTitlePayExercisedYear Born
Mr. Dennis P. CalvertPres, CEO & Chairman314.27kN/A1963
Mr. Charles K. Dargan IICFO & Principal Accounting OfficerN/AN/A1956
Mr. Joseph L. ProvenzanoExec. VP of Operations, Corp. Sec. & Director184.28kN/A1969
Mr. Kenneth Reay CodeChief Science Officer & Director301.2kN/A1947
Dr. Jui Shan Yong Ph.D.Director of Bus. Devel. - AOS SystemN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

BioLargo, Inc. operates as a science, technology, and environmental engineering company. Its platform technologies include Advanced Oxidation System (AOS), CupriDyne, and Isan. The company offers odor and volatile organic compound control products, AOS water treatment technologies, and technologies in the medical and dental fields, as well as professional engineering services. It provides commercial, household, and personal care products, including an animal-bedding additive that controls odor and moisture; and liquid odor control products under the Odor-No-More, Nature's Best Science, Deodorall, and NBS brand names. BioLargo, Inc. was founded in 1989 and is based in Westminster, California.

Corporate Governance

BioLargo, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.